245 related articles for article (PubMed ID: 311787)
1. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
Sagawa A; Abdou NI
J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
[TBL] [Abstract][Full Text] [Related]
2. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.
Sagawa A; Abdou NI
J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952
[TBL] [Abstract][Full Text] [Related]
3. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
Sakane T; Steinberg AD; Reeves JP; Green I
J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
[TBL] [Abstract][Full Text] [Related]
4. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
Kammer GM; Birch RE; Polmar SH
J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
[TBL] [Abstract][Full Text] [Related]
5. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
Sakane T; Steinberg AD; Reeves JP; Green I
J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
[TBL] [Abstract][Full Text] [Related]
6. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by nonsuppressor T cells.
Sakane T; Takada S; Suzuki N; Tsuchida T; Murakawa Y; Ueda Y
J Immunol; 1986 Dec; 137(12):3809-13. PubMed ID: 2946769
[TBL] [Abstract][Full Text] [Related]
7. Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.
Glinski W; Gershwin ME; Steinberg AD
J Clin Invest; 1976 Mar; 57(3):604-14. PubMed ID: 55418
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
9. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
[TBL] [Abstract][Full Text] [Related]
10. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
[TBL] [Abstract][Full Text] [Related]
11. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus.
Bluestein HG; Zvaifler NJ
J Clin Invest; 1976 Feb; 57(2):509-16. PubMed ID: 56343
[TBL] [Abstract][Full Text] [Related]
12. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products.
Litvin DA; Cohen PL; Winfield JB
J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
Moutsopoulos HM; Fauci AS
J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
Kumagai S; Steinberg AD; Green I
J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
[TBL] [Abstract][Full Text] [Related]
15. A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.
Twomey JJ; Laughter AH; Steinberg AD
J Clin Invest; 1978 Sep; 62(3):713-5. PubMed ID: 308514
[TBL] [Abstract][Full Text] [Related]
16. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
[TBL] [Abstract][Full Text] [Related]
17. Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.
Ginsburg WW; Finkelman FD; Lipsky PE
Clin Exp Immunol; 1979 Jan; 35(1):76-88. PubMed ID: 154983
[TBL] [Abstract][Full Text] [Related]
18. Normal T cell regulation of IgG synthesis in systemic lupus erythematosus.
Nies KM; Stevens RH; Louie JS
J Clin Lab Immunol; 1980 Sep; 4(2):69-75. PubMed ID: 6449594
[TBL] [Abstract][Full Text] [Related]
19. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
Utsinger PD; Yount WJ
J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
Starkebaum G; Arend WP
J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
